Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNS
1726
DELISTED
Avanos Medical
AVNS
| $16.6M | ﹤0.01% |
+242,184
| New | +$15.6M |
|
|
EGRX
1727
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $16.5M | ﹤0.01% |
238,421
-50,088
| -17% | -$3.8M |
|
1728
Campbell Soup
CPB
$6.87B
| $16.5M | ﹤0.01% |
450,268
-2,159,632
| -83% | -$88M |
|
1729
TG Therapeutics
TGTX
$7.62B
| $16.5M | ﹤0.01% |
2,944,733
-621,700
| -17% | -$7.1M |
|
|
ENFC
1730
DELISTED
Entegra Financial Corp.
ENFC
| $16.4M | ﹤0.01% |
619,561
+2,893
| +0.5% | +$81.8K |
|
1731
Krystal Biotech
KRYS
$9.66B
| $16.4M | ﹤0.01% |
935,400
-264,600
| -22% | -$4.44M |
|
|
BBT
1732
Beacon Financial Corp
BBT
$2.66B
| $16.4M | ﹤0.01% |
403,850
-7,350
| -2% | -$306K |
|
1733
MPLX
MPLX
$59.7B
| $16.4M | ﹤0.01% |
473,103
-32,122
| -6% | -$1.15M |
|
1734
ProQR Therapeutics
PRQR
$265M
| $16.4M | ﹤0.01% |
846,313
+608,397
| +256% | +$6.47M |
|
|
BRKL
1735
DELISTED
Brookline Bancorp
BRKL
| $16.4M | ﹤0.01% |
979,651
-15,549
| -2% | -$281K |
|
1736
Choice Hotels
CHH
$4.8B
| $16.4M | ﹤0.01% |
+196,345
| New | +$15.4M |
|
|
LLL
1737
DELISTED
L3 Technologies, Inc.
LLL
| $16.3M | ﹤0.01% |
76,838
+9,585
| +14% | +$2M |
|
|
VSI
1738
DELISTED
Vitamin Shoppe Inc.
VSI
| $16.2M | ﹤0.01% |
1,624,763
+220
| +0% | +$2.27K |
|
1739
Fortis
FTS
$28.7B
| $16.2M | ﹤0.01% |
500,323
-48,839
| -9% | -$1.59M |
|
|
PTE
1740
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $16.2M | ﹤0.01% |
33,855
+4,624
| +16% | +$2.67M |
|
1741
Columbus McKinnon
CMCO
$584M
| $16.1M | ﹤0.01% |
408,329
+185,751
| +83% | +$7.76M |
|
|
ECYT
1742
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $16.1M | ﹤0.01% |
907,057
+14,827
| +2% | +$255K |
|
1743
Sony
SONY
$138B
| $16.1M | ﹤0.01% |
1,324,380
-20,250
| -2% | -$223K |
|
|
AD
1744
Array Digital Infrastructure
AD
$3.05B
| $16M | ﹤0.01% |
357,296
+13,200
| +4% | +$532K |
|
|
ALNA
1745
DELISTED
Allena Pharmaceuticals
ALNA
| $16M | ﹤0.01% |
1,489,783
-375,994
| -20% | -$4.13M |
|
1746
Televisa
TV
$1.49B
| $16M | ﹤0.01% |
899,223
+96,673
| +12% | +$1.84M |
|
1747
First Northwest Bancorp
FNWB
$104M
| $15.9M | ﹤0.01% |
1,032,539
-5,568
| -0.5% | -$89.6K |
|
1748
Cooper-Standard Automotive
CPS
$558M
| $15.9M | ﹤0.01% |
132,500
-32,618
| -20% | -$4.37M |
|
1749
Itron
ITRI
$4.54B
| $15.9M | ﹤0.01% |
247,629
+22,823
| +10% | +$1.44M |
|
1750
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $15.9M | ﹤0.01% |
+658,882
| New | +$17.1M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.